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Summary
Tocopherols and tocotrienols are food ingredients that are be-
lieved to have a positive effect on health. The most studied property
of both groups of compounds is their antioxidant action. Previously,
we found that tocopherols and diverse tocopherol derivatives can
inhibit the activity of human glutathione S-transferase P1-1 (GST
P1-1). In this study we found that GST P1-1 is also inhibited, in
a concentration-dependent manner, byα- and γ-tocotrienol. The
concentration giving 50% inhibition of GST P1-1 is 1.8± 0.1µM
for α-tocotrienol and 0.7± 0.1µM for γ-tocotrienol. This inhibi-
tion of GST P1-1 is noncompetitive with respect to both substrates
CDNB and GSH. We also examined the 3D structure of GST P1-1
for a possible tocopherol/tocotrienol binding site. The enzyme con-
tains a very hydrophobic pit-like structure where the phytyl tail of
tocopherols and tocotrienols could fit in. Binding of tocopherol and
tocotrienol to this hydrophobic region might lead to bending of the
3D structure. In this way tocopherols and tocotrienols can inhibit
the activity of the enzyme; this inhibition can have far-reaching
implications for humans.
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INTRODUCTION
Vitamin E is the generic name for both tocopherol and to-
cotrienol derivatives. Tocopherols and tocotrienols both consist
of a common chromanol head (with two rings: one phenolic and
one heterocyclic) and a 16-carbon tail attached at the 2-position.
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The tocotrienols differ from the tocopherols only in the tail. To-
copherols have a saturated phytyl side chain, whereas the tail of
tocotrienols is unsaturated and forms an isoprenoid chain (1–3).
Tocotrienols and tocopherols are further divided into several vi-
tamers (α,β, δ, andγ ) depending on the number and position of
methyl groups on the chroman head (Fig. 1) (1–3). They are both
used as food additives. The natural sources of tocopherol mainly
consist of nuts and common vegetable oils (i.e., wheat germ,
sunflower (4)). Tocotrienols are minor plant constituents, with a
relative high abundance in cereal grains (i.e., oat, barley, and rye)
and certain vegetable oils (i.e., palm oil and rice bran oil; (4)).
Both tocopherols and tocotrienols are well recognized for
their antioxidative effect. It has been stated that, in vitro, the
tocotrienols are more potent antioxidants than the tocopherols
(3). Aside from their function as antioxidants, tocotrienols are re-
ported to reduce plasma cholesterol levels and lipid- and
nonlipid-related risk factors for cardiovascular disease (4).
Tocopherols and diverse tocopherol derivatives can inhibit the
activity of glutathione S-transferase P1-1 (GST P1-1; (5, 6)).
This detoxification isoenzyme is the most prominent GST in
erythrocytes and is also present in human skin (7, 8). In this
study we examined the effect of two vitamers of tocotrienol on
the activity of GST P1-1.
MATERIALS AND METHODS
Chemicals
Tocotrienols were a gift from BASF (Stuttgart, Germany);
1-chloro-2,4-dinitrobenzene (CDNB) and glutathione S-
transferase P1-1 (from human placenta) were obtained from
Sigma, St. Louis, Missouri, USA. Reduced glutathione (GSH)
was obtained from ICN Biomedicals Inc., Costa Mesa,
California, USA. All other chemicals were of analytical grade
purity.
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Figure 1. Molecular structure of tocopherols and tocotrienols.
The naturally occurring vitamers—α, β, γ, andδ—have methy-
lation patterns as indicated.
Assay of Glutathione S-Transferase Activity
GST activity was measured as described by Mannervik and
Guthenberg (8) with slight modifications. In short, the reaction
of 1 mM CDNB with 1 mM GSH in 100 mM potassium phos-
phate, pH 6.5, at 37◦C was monitored spectrophotometrically
by recording the increase in absorbance at 340 nm. Effects of
various concentrations ofα- andγ -tocotrienol (final concentra-
tion 0.25µM–5µM) on GST activity were determined. A stock
solution of tocotrienol was prepared in ethanol. The final con-
centration of ethanol in the incubation mixture was 1% v/v; this
concentration of ethanol had no effect on GST activity. The mix-
ture of the GST enzyme (0.0095 U/ml in buffer) with tocotrienol
was incubated for 2 min at 37◦C before activity measurement.
A correction for the spontaneous reaction was made for the for-
mation of the conjugate of GSH and CDNB in the absence of en-
zyme and in the presence of ethanol (1%). Ethanol was added as
a control because tocotrienol was dissolved in ethanol. To study
the inhibitory mechanism, substrate concentrations (CDNB or
GSH) were varied. When CDNB was varied, the GSH concen-
tration was kept at 1 mM and vice versa, the concentration of
tocotrienol was constant (1µM).
3D Structure Evaluation
The PDB file for human GSTP1-1 with GSH bound
[PDB ID: 7GSS (9)] was downloaded from the PDB database
〈http://www.rcsb.org/pdb〉 (10) and examined with Rasmol
(version 2.6,〈http://www.umass.edu/microbio/rasmol〉. Hydro-
phobic amino acids were color-coded light gray (green in full
color version) using the Rasmol “color hydrophobic light gray
Figure 2. Effect ofα-tocotrienol (¥) andγ -tocotrienol (¤) on
the activity of GST P1-1. The IC50 values are 1.8± 0.1 µM
for α-tocotrienol and 0.7± 0.1 µM for γ -tocotrienol. Each
point denotes the mean± standard error of the mean of three
experiments.
(green in full color version)” setting. The G-site of GSTP1-1
was previously identified by Reinemer et al. (11). The nonhy-
drophobic amino acids in this region were color-coded black
(blue in full color version).
RESULTS
Bothα- andγ -tocotrienol inhibited the GST P1-1 activity in
a concentration-dependent manner (Fig. 2). The concentration
giving 50% inhibition of the GST P1-1 activity (IC50) is 1.8±
0.1µM for α-tocotrienol and 0.7± 0.1µM for γ -tocotrienol.
The nature of the inhibition ofγ -tocotrienol was studied by
making Lineweaver-Burk plots for both the substrates CDNB
and GSH. GST activity was measured with variable concentra-
tions of either CDNB (Fig. 3) or GSH (data not shown) in the
Figure 3. Lineweaver-Burk plot showing noncompetitive in-
hibition of human GST P1-1 towards CDNB by 1µM
γ -tocotrienol. The Km and Vmax (mean± standard error of
the mean) for CDNB (•) are, respectively, 1.1± 0.1 mM
and 20.7± 2.5 (µmol ·min−1 ·mg−1). In the presence of
γ -tocotrienol (◦), these values are 1.3± 0.1 mM and 14.6±
1.2 (µmol ·min−1 ·mg−1).
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Figure 4. Three-dimensional structure of human GST P1-1
with GSH bound. (The figure is shown in full color at http://
taylorandfrancis.metapress.com/link.asp?id=103791.) GSH is
shown as a ball-structure. The hydrophobic parts are light gray
(green in full color version) and the hydrophilic parts are gray
(white in full color figure). The black part (blue in full color
version) is the hydrophilic part of the glutathione binding site.
The dark gray part (orange in full color version) depicts the hy-
drophilic amino acids at the interface between the two monomers
of the human GST P1-1. The hydrophobic region to which to-
copherols and tocotrienols are proposed to bind is white (purple
in full color version).
presence of a fixed concentration (1µM) of γ -tocotrienol. GST
showed characteristic Michaelis-Menten behavior towards both
substrates (Fig. 3). As depicted in Fig. 3,γ -tocotrienol lowered
the Vmax, but did not change the Km for CDNB. The same results
are obtained for GSH.
Three-dimensional evaluation of the GSTP1-1 protein struc-
ture revealed that there are surprisingly few hydrophobic amino
acids present in the contact region of the two monomers. The
hydrophilic amino acids in the contact region are color-coded
dark gray (orange in full color version) in Fig. 4. Further evalu-
ation of possible hydrophobic binding locations for tocopherols
and tocotrienols revealed that each monomer contains a region
consisting of twoα-helix fragments (15–22 and 68–78), with
hydrophobic amino acids all on one side and folded towards
each other, and a third hydrophobic two-amino acid fragment
(150–151) that also folds to the same region (white [purple in
full color version] fragment in Fig. 4). This region is very close
to the GSH binding site (G-site) (black [blue in full color ver-
sion] part in Fig. 4 is hydrophilic part of G-site); the minimum
distance between a GSH member atom and the nearest atom in
the region is only 6.5̊A.
DISCUSSION
Comparable to tocopherol andα-tocopherol derivatives, to-
cotrienols inhibit the activity of GST P1-1 in a concentration-
dependent manner. The IC50 of the tocotrienols (α-tocotrienol
1.8µM andγ -tocotrienol 0.7µM) are in the same range of the
IC50 of the tocopherols (α-tocopherol 0.7µM andδ-tocopherol
0.8µM) (6). So the tocopherols and the tocotrienols have a com-
parable potency to inhibit the GST P1-1 activity. The antioxidant
activity of tocopherols and tocotrienols is also comparable, since
the group that displays the central antioxidant activity, i.e., the
chromanol head, is identical. Both tocopherols and tocotrienols
scavenge the chain propagating peroxyl radical in the process
of peroxidation of lipids (3). Although it has been reported that,
in vitro, the tocotrienols are more potent antioxidants than the
tocopherols, tocotrienols have a lower bioavailability after oral
ingestion (3).
The inhibition of GST P1-1 by tocotrienols is, similar to the
inhibition by tocopherols (5), noncompetitive with respect to
both substrates CDNB and GSH. We have previously suggested
that the probable mechanism of GST inhibition by tocopherols
and tocopherol derivatives is the induction of conformational
changes of the enzyme. These conformational changes could
be caused by volume increases and structural modifications of
lipophilic regions that are present in the interface between the
two monomers of the GST enzyme (12).
The three-dimensional evaluation of the GST structure
showed that binding of tocopherols or tocotrienols in the con-
tact region of the two monomers is unlikely because a large
hydrophilic fragment of amino acids is present in this region
(dark gray [orange in full color version] part in Fig. 4). How-
ever, a very hydrophobic pit-like structure, where the phytyl tail
of tocopherols and tocotrienols could fit in, is present just below
the G-site. It is likely that binding of hydrophobic tocopherol or
tocotrienol occurs preferentially in this hydrophobic region.
Several groups found that GST P1-1 can bind various hy-
drophobic compounds that can induce significant conforma-
tional changes of the protein. This resulted in a marked re-
duction of enzyme activity. The amino acid sequences involved
in the binding of these hydrophobic compounds are residues
141–156 (13–15). It appeared that binding of a hydrophobic
compound (e.g., 1-amino-8-naphtalene sulfonic acid) results in
noncompetitive inhibition (toward substrates, GSH and CDNB)
of the GST activity (15). The pit-like structure described in
this study (Fig. 4) contains an overlapping region (residues
150–151) with the hydrophobic binding region described in ear-
lier studies (residues 141–156). Our three-dimensional struc-
ture analyses showed that sequences 150–151 within the se-
quences 141–156 are the most important for the binding of
tocopherols/tocotrienols. These two amino acids are hydropho-
bic and are the only amino acids that have the right orientation
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in the sequence 141–156 to interact with lipophilic compounds.
Together with the amino acids in sequences 15–22 and 68–78,
the amino acids in sequence 150–151 form the pit-like structure
in GST P1-1, where the tail of tocopherol and tocotrienol fits
in. Binding of tocopherols and tocotrienols to this region might
lead to the bending of the 3D structure by pushing the three
hydrophobic regions apart, resulting in distorting the G-site and
possibly the hydrophobic-site (H-site).
Although the tocopherols and tocotrienols share the same
mechanism of inhibition of GST P1-1, their retention in the
body is different. Theα-tocopherol transfer protein (α-TTP)
binds toα-tocopherol with high affinity and specificity. This
protein enhances transfer ofα-tocopherol between membranes
and determines the level of plasma and tissueα-tocopherol in the
different organs. The affinity ofα-tocotrienol forα-TTP is only
12% of that ofα-tocopherol (16). Due to this lower affinity of
α-tocotrienol compared toα-tocopherol and due to lower intake
of α-tocotrienol compared toα-tocopherol, the concentration of
α-tocopherol in most organs is much higher than the concentra-
tion of α-tocotrienol (17).
Less than 2% of the total amount of vitamin E in most vital
tissues consists of tocotrienol. Surprisingly, dietary tocotrienols
accumulate specifically in the skin (18) because up to 13% of
total vitamin E in skin consists of tocotrienol (17). Vitamin E
in the skin has multiple important functions besides the antiox-
idant function. For example, skin has been suggested to be an
important storage site for vitamin E (19) and vitamin E has a reg-
ulatory role in maintaining the barrier function of the skin (17).
It is known that the skin also contains a relatively high amount
of GST P1-1 (20). GST P1-1 detoxifies a wide variety of xeno-
biotics including (+)-anti-7,8-dihydroxy-9,10-epoxy-7,8,9,
10-tetrahydrobenzo[a]pyrene ((+)-anti-BPDE) (21). This com-
pound is a well-known mutagenic, tumorigenic, and carcino-
genic compound. Tocotrienols may reduce the defense against
this noxious compound. This can have far-reaching consequen-
ces in human health.
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